DeepMed Research

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1934-01-01

Employees: 1K

Market Cap: -

Website: http://www.tums.ac.ir

Clinical Trials

Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure

Phase 3

Not yet recruiting

Conditions: Heart Failure

Interventions: Other: placebo
Other: Acetazolamide

First Posted Date: 2023-07-11

Last Posted Date: 2023-08-01

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 130

Registration Number: NCT05940220

Locations: 🇮🇷
Houshang bavandpour karvane, Tehran, Tehran Heart Center, Iran, Islamic Republic of

Comparison of the Clinical Response of Total Neoadjuvant Treatment of Two Methods of Long-term or Short-term Chemoradiotherapy in Rectal Cancer

Not Applicable

Not yet recruiting

Conditions: Locally Advanced Rectal Carcinoma

Interventions: Radiation: Long course radiotherapy with concurrent capecitabine(825mg/m2)
Radiation: Short course radiotherapy with concurrent capecitabine(825mg/m2)

First Posted Date: 2023-06-27

Last Posted Date: 2023-06-27

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 114

Registration Number: NCT05920928

Assessment of the Efficacy of Letrozole in the Treatment of Ectopic Pregnancy

Phase 1

Active, not recruiting

Conditions: Ectopic Pregnancy

Interventions: Drug: methotrexate
Drug: Letrozole

First Posted Date: 2023-06-26

Last Posted Date: 2024-03-26

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 150

Registration Number: NCT05918718

Locations: 🇮🇷
Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of

Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery

Phase 1

Recruiting

Conditions: Myocardial Ischemia
Myocardial Infarction
Myocardial Stunning

Interventions: Biological: mitochondria and MSC-derived exosomes

First Posted Date: 2022-12-30

Last Posted Date: 2022-12-30

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 20

Registration Number: NCT05669144

Locations: 🇮🇷
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients

Phase 1

Conditions: Perianal Fistula in Patients With Crohn's Disease

Interventions: Other: placenal MSC derived exosomes

First Posted Date: 2022-08-12

Last Posted Date: 2022-08-12

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 80

Registration Number: NCT05499156

Locations: 🇮🇷
Division of Colorectal Surgery, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran, Islamic Republic of

The Efficacy of Exercise Therapy in Patients With Inflammatory Bowel Disease

Not Applicable

Conditions: Sarcopenia
Inflammatory Bowel Diseases

Interventions: Other: Exercise

First Posted Date: 2022-07-13

Last Posted Date: 2022-07-13

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 56

Registration Number: NCT05455762

Locations: 🇮🇷
Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of

Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula

Phase 1

Recruiting

Conditions: Fistula Perianal

Interventions: Other: placenta-MSCs derived exosomes

First Posted Date: 2022-06-02

Last Posted Date: 2022-11-02

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 80

Registration Number: NCT05402748

Locations: 🇮🇷
Division of Colorectal Surgery, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran, Islamic Republic of

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Phase 4

Conditions: Adult ALL
Multiple Sclerosis, Relapsing-Remitting
Vitamin D3 Deficiency

Interventions: Dietary Supplement: vitamin D3
Dietary Supplement: 25(OH)D3

First Posted Date: 2022-04-22

Last Posted Date: 2022-04-22

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 54

Registration Number: NCT05340985

GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes

Phase 3

Completed

Conditions: Polycystic Ovary Syndrome
Infertility, Female

Interventions: Drug: HRT
Drug: Long GnRH agonist + HRT

First Posted Date: 2022-01-13

Last Posted Date: 2022-01-13

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 128

Registration Number: NCT05189873

Locations: 🇮🇷
Arash women's hospital,Tehran university of medical sciences, Tehran, Iran, Islamic Republic of

Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients

Phase 2

Conditions: COVID-19 Vaccines
Immune System Tolerance
Hematopoietic Stem Cell Transplantation (HSCT)

Interventions: Biological: Pasocovac vaccine

First Posted Date: 2022-01-11

Last Posted Date: 2022-05-09

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 100

Registration Number: NCT05185817

Locations: 🇮🇷
Hematology, Oncology, and Stem Cell Transplantation Research Center of shariaty Hospital, Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy